Profil Financier
Pablo Legorreta occupe actuellement le rang #839 du classement mondial StarFortune (secteur finance & investissement). Fortune nette estimée : $5.1 B (+$82 sur 24h).
Pablo Legorreta is the founder of Royalty Pharma, the world's biggest acquirer of pharmaceutical royalty streams.
Royalty Pharma, which went public in 2020, has collected revenue slices of blockbuster drugs like Humira, Imbruvica, Lyrica, and Xtandi.
A former investment banker at Lazard Frères, Legorreta started Royalty Pharma in New York as a private equity vehicle in 1996.
In 2025, Royalty Pharma acquired its external investment manager RP Management in a $1.1 billion deal. Legorreta owned 100% of RPM until 2024, when he gave just under half his stake to employees